SCHEMBL6479694

SCHEMBL6479694

[CH2]n1c(C(C)(C)C)nc2ccccc21

nearest known ligand 0.46

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
CNR2 P34972 2/20 0.46
ADORA2A P29274 1/20 0.42
SMN1; SMN2 Q16637 3/20 0.42
PTPN2 P17706 1/20 0.42
PTPN1 P18031 1/20 0.42
GAA P10253 3/20 0.40
MAPK1 P28482 2/20 0.40
PKM P14618 1/20 0.40
ALDH1A1 P00352 3/20 0.39
KDM4E B2RXH2 2/20 0.39
HPGD P15428 2/20 0.39
ATM Q13315 1/20 0.39
LMNA P02545 2/20 0.39
MAPT P10636 1/20 0.39
GLA P06280 1/20 0.38
L3MBTL1 Q9Y468 1/20 0.38
HTT P42858 1/20 0.38
ALOX15 P16050 1/20 0.38
NOS2 P35228 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6493311 0.85 MAPK1 (0.44) CNR2SMN1; SMN2GAAMAPK1PKM
SCHEMBL6479785 0.85 MAPK1 (0.44) CNR2SMN1; SMN2GAAMAPK1PKM
SCHEMBL5851398 0.81 ALDH1A1 (0.54) SMN1; SMN2MAPK1ALDH1A1KDM4EHPGD
SCHEMBL6479700 0.78 SMN1; SMN2 (0.58) CNR2SMN1; SMN2GAAPKMALDH1A1
SCHEMBL19073863 0.77 NOS2 (0.55) CNR2ADORA2ASMN1; SMN2PTPN2PTPN1
SCHEMBL15471712 0.77 CNR2 (0.46) CNR2ADORA2ASMN1; SMN2PTPN2PTPN1
SCHEMBL7762123 0.74 HTT (0.59) SMN1; SMN2GAAMAPK1PKMALDH1A1
SCHEMBL12026134 0.74 MAPK1 (0.61) CNR2SMN1; SMN2MAPK1ALDH1A1HTT
SCHEMBL3968378 0.74 CNR2 (0.52) CNR2ADORA2ASMN1; SMN2PTPN2PTPN1
SCHEMBL10247393 0.74 HSD17B10 (0.53) SMN1; SMN2GAAMAPK1ALDH1A1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6962938-B2 Spiro-cyclic β-amino acid derivatives as inhibitors of matrix metalloproteases and TNF-α converting enzyme (TACE) BRISTOL-MYERS SQUIBB PHARMA COMPANY (US) 2005-11-08 US disclosed
US-6720329-B2 ANTIINFLAMMATORY AGENTS BRISTOL-MYERS SQUIBB PHARMA 2004-04-13 US disclosed